Pharmaceutical Care Management Association
New PCMA Research: State Legislative Proposals Restricting Access to Generic Medicines Would Increase Costs $29 Billion Over 10 Years
Published in Medical Letter on the CDC and FDA, October 19th, 2008
"In this economy, the worst thing you can do is pursue policies which increase the cost of prescription drugs for payors and patients alike. The Food and Drug Administration, medical groups, and others maintain that generic substitution for all drug classes is safe and clinically appropriate," said PCMA President and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- JAMA and Archives Journals
Changing dosing, administration of anthrax vaccine reduces side effects - McGill University Health Centre
Hospital delays under scrutiny by researchers at the MUHC - Norwegian Institute of Public Health
Thin men more vulnerable to osteoporosis and bone fractures than other older men - AngioDynamics, Inc.
AngioDynamics Reports Financial Results for Fiscal First Quarter 2009 - AxioMed Spine Corporation
AxioMed Spine Corporation Initiates Pivotal Study - Contact Lens
Study results from University of Miami in the area of contact lens published - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
